BPC-157 — Stack & Timing
Educational timing and stacking information based on how BPC-157 has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how BPC-157 has been studied and commonly used.
Commonly studied timing
Animal studies and anecdotal clinical use suggest administration on an empty stomach may optimize absorption; post-workout timing is commonly recommended by practitioners to support tissue recovery, though no controlled human trials confirm optimal timing.
Commonly paired with
Growth hormone-releasing peptides are combined with BPC-157 by some practitioners who claim synergistic tissue repair effects
Both peptides are believed to support tissue healing and are commonly paired in injury recovery protocols
May complement BPC-157's proposed tendon and connective tissue repair mechanisms
Cofactor for collagen synthesis; sometimes paired with peptide protocols aimed at tissue repair
Safety & interactions
BPC-157 has not been approved by the FDA for human use, and long-term safety data in humans is absent. It is classified as a research compound. Injectable forms carry risks of infection, improper dosing, and contamination — particularly when self-administered. The available review article is of moderate quality with no human population data reported.
- •Potential interaction with anticoagulants or blood-thinning agents (theoretical, based on proposed angiogenic effects)
- •Possible additive effects with other peptide hormones or growth factors — clinical significance unknown
Individuals with a personal or family history of cancer should exercise extreme caution given BPC-157's proposed pro-angiogenic properties. Pregnant or breastfeeding individuals, minors, and those with active infections or immune disorders should avoid use. Anyone considering use should consult a licensed physician, as human safety data is lacking.